Skip to main content
. 2022 Apr 8;26(2):190–198. doi: 10.14701/ahbps.21-144

Table 3.

Patient’s outcome according to group

Clinical outcome and management Total (n = 77) Adult group (≥ 18 yr; n = 52) Pediatric group (< 18 yr; n = 25) p-value
Received somatostatin 0.613
Yes 13 (16.9) 8 (15.4) 5 (20.0)
No 64 (83.1) 44 (84.6) 20 (80.0)
Management 0.104
Operative 47 (61.0) 35 (67.3) 12 (48.0)
Conservative 30 (39.0) 17 (32.7) 13 (52.0)
Management 0.07
Successful conservative 16 (20.8) 8 (15.4) 8 (32.0)
Failed conservative 14 (18.2) 9 (17.3) 5 (20.0)
Operative management 47 (61.0) 35 (67.3) 12 (48.0)
Time from admission to operation (h) 0.899
Mean ± SD 13.8 ± 31.09 14.13 ± 33.84 12.93 ± 22.89
Preoperative ERCP 0.459
Yes 12 (15.6) 7 (13.5) 5 (20.0)
No 65 (84.4) 45 (86.5) 20 (80.0)
Intervention on the Pancreas
Distal pancreatectomy 24 (31.2) 16 (30.8) 8 (32.0) 0.913
Whiple 2 (2.6) 2 (3.8) 0 (0) 0.320
Hemostasisa) 22 (28.6) 19 (36.5) 3 (12.0) 0.026
Operation in another abdominal organ 0.530
Yes 47 (61) 33 (63.5) 14 (56.0)
No 30 (39.0) 19 (36.5) 11 (44.0)
Blood transfusion 0.018
Yes 30 (39.0) 25 (48.1) 5 (20.0)
No 47 (61.0) 27 (51.9) 20 (80.0)
Length of hospital stay (day) 0.069
Mean ± SD 25.4 ± 25.43 29.05 ± 29.17 17.8 ± 12.22
Range 1–161 1–161 2–42
Length of ICU stay (day) 0.098
Mean ± SD 10.72 ± 16.62 12.9 ± 19 6.2 ± 8.66
Range 0–83 0–83 0–38
Outcome 0.203
Death 8 (10.4) 7 (13.5) 1 (4.0)
Survive 69 (89.6) 45 (86.5) 24 (96.0)
Complication
Abscess 8 (10.4) 6 (11.5) 2 (8.0) 0.634
VAP 4 (5.2) 2 (3.8) 2 (8.0) 0.442
Renal failure 6 (7.8) 5 (9.6) 1 (4.0) 0.389
Liver failure 2 (2.6) 1 (1.9) 1 (4.0) 0.592
Seizure 1 (1.3) 0 (0) 1 (4.0) 0.147
Fever 26 (3.8) 22 (42.3) 4 (16.0) 0.022

Values are presented as number (%).

SD, standard deviation; ERCP, endoscopic retrograde cholangiography; ICU, intensive care unit.

a)One case had angiographic embolization only.